Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 60 results:
Συντάκτης [ Τίτλος(Asc)] Τύπος Έτος
Φίλτρα: Συντάκτης is Georgianos, Panagiotis I  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
W
Georgianos, P. I., Papachristou E., & Liakopoulos V. (2023).  Which blood pressure threshold indicates a therapeutic benefit for patients with chronic kidney disease?. Hypertens Res. 46(4), 890-892.
V
Roumeliotis, S., Roumeliotis A., Georgianos P. I., Thodis E., Schurgers L. J., Maresz K., et al. (2022).  VItamin K In PEritonial DIAlysis (VIKIPEDIA): Rationale and study protocol for a randomized controlled trial.. PLoS One. 17(8), e0273102.
T
Georgianos, P. I., Vaios V., Eleftheriadis T., Papachristou E., & Liakopoulos V. (2023).  Therapeutic Advances in Diabetic Kidney Disease.. Int J Mol Sci. 24(3), 
S
Georgianos, P. I., Vaios V., Divani M., & Liakopoulos V. (2023).  Should we discontinue RAS-inhibitor therapy in patients with advanced CKD?. Expert Opin Pharmacother.
Georgianos, P. I., Divani M., Eleftheriadis T., Mertens P. R., & Liakopoulos V. (2019).  SGLT-2 inhibitors in Diabetic Kidney Disease: What Lies Behind their Renoprotective Properties?. Curr Med Chem. 26(29), 5564-5578.
R
Georgianos, P. I., Sarafidis P. A., & Zebekakis P. E. (2014).  Renin-angiotensin system blockade and exercise-induced increase in aortic stiffness.. J Clin Hypertens (Greenwich). 16(7), 475-6.
P
Georgianos, P. I., Vaios V., Eleftheriadis T., Zebekakis P. E., & Liakopoulos V. (2020).  Pulse wave velocity assessment for cardiovascular risk prognostication in ESKD: weighing recent evidence.. Curr Vasc Pharmacol.
Georgianos, P. I., & Sarafidis P. A. (2015).  Pro: Should we move to more frequent haemodialysis schedules?. Nephrol Dial Transplant. 30(1), 18-22.
Tsiagka, D., Georgianos P. I., Pikilidou M. I., Vaios V., Roumeliotis S., Syrganis C., et al. (2022).  Prevalence, recurrence and seasonal variation of hyperkalemia among patients on hemodialysis.. Int Urol Nephrol. 54(9), 2327-2334.
Vareta, G., Georgianos P. I., Vaios V., Sgouropoulou V., Georgianou E. I., Leivaditis K., et al. (2022).  Prevalence of Apparent Treatment-Resistant Hypertension in ESKD Patients Receiving Peritoneal Dialysis.. Am J Hypertens. 35(11), 918-922.
Tsikliras, N., Georgianos P. I., Vaios V., Minasidis E., Anagnostara A., Chatzidimitriou C., et al. (2020).  Prevalence and control of hypertension among patients on haemodialysis.. Eur J Clin Invest. 50(10), e13292.
Sarafidis, P. A., Georgianos P. I., & Lasaridis A. N. (2011).  PPAR-γ agonism for cardiovascular and renal protection.. Cardiovasc Ther. 29(6), 377-84.
Sarafidis, P. A., Georgianos P. I., Malindretos P., & Liakopoulos V. (2012).  Pharmacological management of hypertensive emergencies and urgencies: focus on newer agents.. Expert Opin Investig Drugs. 21(8), 1089-106.
O
Hatzistavri, L. S., Sarafidis P. A., Georgianos P. I., Tziolas I. M., Aroditis C. P., Zebekakis P. E., et al. (2009).  Oral magnesium supplementation reduces ambulatory blood pressure in patients with mild hypertension.. Am J Hypertens. 22(10), 1070-5.
Georgianos, P. I., Zebekakis P. E., & Liakopoulos V. (2019).  Optimal diastolic blood pressure range in intensive systolic targets: Resolving the controversy between observational and intention-to-treat analyses.. J Clin Hypertens (Greenwich). 21(7), 919-921.
Georgianos, P. I., & Sarafidis P. A. (2015).  Opponent's comment.. Nephrol Dial Transplant. 30(1), 27-8.
M
Georgianos, P. I., Sarafidis P. A., Liakopoulos V., Balaskas E. V., & Zebekakis P. E. (2016).  Mineralocorticoid Receptor Antagonism for Cardiovascular Protection in End-Stage Renal Disease: New Data But the Controversy Continues.. J Clin Hypertens (Greenwich). 18(3), 197-9.
Georgianos, P. I., Vaios V., Eleftheriadis T., Zebekakis P., & Liakopoulos V. (2017).  Mineralocorticoid Antagonists in ESRD: An Overview of Clinical Trial Evidence.. Curr Vasc Pharmacol. 15(6), 599-606.
L
Georgianos, P. I., Liakopoulos V., & Zebekakis P. E. (2019).  Low-dose combination therapy to control sustained ambulatory hypertension-Basic principles and future directions.. J Clin Hypertens (Greenwich). 21(2), 249-251.
I
Georgianos, P. I., Vaios V., Sgouropoulou V., & Liakopoulos V. (2022).  The interaction of estimated glomerular filtration rate with circadian blood pressure variation: do not forget the impact of albuminuria.. J Hypertens. 40(7), 1432-1433.
Liakopoulos, V., Georgianos P. I., Demirtzi P., Vaios V., Kalathas T., & Zebekakis P. E. (2018).  Icodextrin-associated generalized exfoliative skin rash in a CAPD patient: a case-report.. BMC Nephrol. 19(1), 293.
H
Georgianos, P. I., Vaios V., Sgouropoulou V., Eleftheriadis T., Tsalikakis D. G., & Liakopoulos V. (2022).  Hypertension in Dialysis Patients: Diagnostic Approaches and Evaluation of Epidemiology.. Diagnostics (Basel). 12(12), 
Sarafidis, P. A., Georgianos P. I., Germanidis G., Giavroglou C., Nikolaidis P., Lasaridis A. N., et al. (2012).  Hypertension and symptomatic hypokalemia in a patient with simultaneous unilateral stenoses of intrarenal arteries and mesangioproliferative glomerulonephritis.. Am J Kidney Dis. 59(3), 434-8.
Georgianos, P. I., Champidou E., Liakopoulos V., Balaskas E. V., & Zebekakis P. E. (2018).  Home blood pressure-guided antihypertensive therapy in chronic kidney disease: more data are needed.. J Am Soc Hypertens. 12(4), 242-247.
Georgianos, P. I., Sarafidis P. A., Malindretos P., Nikolaidis P., & Lasaridis A. N. (2011).  Hemodialysis reduces augmentation index but not aortic or brachial pulse wave velocity in dialysis-requiring patients.. Am J Nephrol. 34(5), 407-14.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές